| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Atai Life Sciences N.V. last filed a Form 4 in September 2024, as 10% Owner at CMPS. Atai Life Sciences N.V.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 6,905,774 shares of CMPS. The CMPS filings lean toward selling, a net 2,660,000 shares.
Atai Life Sciences N.V. has 1 Form 4 filing on record in September 2024, as 10% Owner at COMPASS Pathways (CMPS), 2024.
The 1 reported transaction was 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $16.1M.
The only open-market sale was 2,660,000 shares of CMPS at an average $6.05 on September 26, 2024, about $16.1M.
Shares as reported in the last Form 4 for each company; the most recent is from September 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | CMPS Compass Pathways Plc | 10% Owner | Sell | 2,660,000 | $6.05 | $16,093,000.00 | -27.8% |